Lenomed
Shanghai, China · Founded 2014 · $18.1M raised
- Headquarters
- Shanghai
- Founded
- 2014
- Business Model
- B2B
- Website
- lenomed.com.cn
- Total Funding
- $18.1M
- Last Round
- $2.8M SeedJul 2025
- Rounds
- 2
About
LenoMed Medical (凯联医疗科技) is a Shanghai-based medical device company specializing in micro-drug infusion technology for diabetes and endocrinology. Founded in 2014, the company develops and manufactures the InnoTech insulin pump — a closed-loop system integrating continuous glucose monitoring (CGM) directly with an insulin delivery mechanism for automated insulin delivery. LenoMed has over 15 years of R&D experience in infusion technology and offers a range of insulin pumps, drug infusion pumps, and disposables. Clinical trials have demonstrated non-inferiority to the Medtronic MMT-712 insulin pump. The company has raised $22.8M across three funding rounds and is backed by investors including F-Prime Capital, Eight Roads Ventures, and Oriental Fortune Capital.
Summary
Lenomed is a Biotech company based in Shanghai, China, founded in 2014. It has raised $18.1M in total across 2 rounds, most recently a $2.8M Seed round in Jul 2025. Investors include Oriental Fortune Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...